• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

G9U:GR

0.669 EUR 0.015 2.29%

As of 03:11:17 ET on 04/16/2014.

Snapshot for TiGenix NV (G9U)

Open: 0.640 Day's Range: 0.627 - 0.669 Volume: 0
Previous Close: 0.654 52wk Range: 0.149 - 1.007 1-Yr Rtn: -25.42%

Stock Chart for G9U

No chart data available.
  • G9U:GR 0.669
  • 1D
  • 1M
  • 1Y
0.654
Interactive G9U Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for G9U

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) -0.1080
Est. PEG Ratio -
Market Cap (M EUR) 107.36
Shares Outstanding (M) 160.48
30 Day Average Volume 672
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/20/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for G9U

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for G9U

TiGenix N.V. is a biomedical company focused on cell therapy. The Company researches and develops treatments for autoimmune and inflammatory diseases.

Eduardo Bravo Fernandez De AraozCEO/Managing DirectorClaudia D AugustaCFO/Secy/Compliance Officer
Wilfried DalemansChief Technology OfficerHans HerklotsDir:Investor & Media Relations
More Company Profile & Key Executives for G9U

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil